FdaApplication
NDA 208603
Identifiers
- fda_app_no: NDA208603
Properties
| Property | Value |
|---|---|
| applicant_name | ZYLA LIFE SCIENCES US INC |
| application_type | NDA |
| approval_date | 2017-01-09 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARYMO ER | MORPHINE SULFATE | 60MG | TABLET, EXTENDED RELEASE;ORAL |
| ARYMO ER | MORPHINE SULFATE | 30MG | TABLET, EXTENDED RELEASE;ORAL |
| ARYMO ER | MORPHINE SULFATE | 15MG | TABLET, EXTENDED RELEASE;ORAL |
3 products